Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds
CA 2288778 A1 · Owner: App, Harald · Inventors: App, Harald; Mcmahon, Gerald; Tang, Peng C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed in part towards methods of modulating the function of serine/threonine protein kinases with quinazoline-based compounds. The methods incorporate cells that express a serine/threonine protein kinase such as RAF. In addition, the invention describes methods of preventing and treating serine/threonine protein kinase-related abnormal conditions in organisms with a compound identified by the invention. Furthermore the , invention pertains to quinazoline compounds and pharmaceutical compositions comprising these compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 1, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 1, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 1, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.